Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002235177 | SCV001711492 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000868877 | SCV001803035 | likely benign | not provided | 2019-11-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279581 | SCV002565735 | likely benign | Ehlers-Danlos syndrome | 2020-09-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169153 | SCV003913576 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003895292 | SCV004715866 | likely benign | COL5A1-related disorder | 2022-01-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |